Even after Protein A, impurities remain. We implemented a two-step polishing phase:
We moved from a conventional stirred-tank model to implementing a single-use bioreactor (SUB) strategy for the clinical launch. A Mab A Case Study In Bioprocess Development
Even after Protein A, impurities remain. We implemented a two-step polishing phase:
We moved from a conventional stirred-tank model to implementing a single-use bioreactor (SUB) strategy for the clinical launch.